NeuroFore
PrivateLast Round
Grant
Apr 15, 2026
Total Funding Raised
$37,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NeuroFore is a biotechnology company that is developing a revolutionary AI-based diagnostic application for the early diagnosis of Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Government Contracts, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroFore Comparables
Compare NeuroFore with similar companies based on industry and business-model similarity.
NeuroFore Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2026 | ||||
| Grant | Nov 19, 2025 |
NeuroFore Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship | Grant |
| Sling Health STL | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
$25K grant from Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship.
- Nov 19, 2025
$10K grant received from Skandalaris Center.
NeuroFore Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroFore's valuation, stock price, and market status.